161 related articles for article (PubMed ID: 1519930)
1. [Chemotherapy-associated hemolytic uremic syndrome--a case report].
Kikuchi H; Kanamaru R
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1927-9. PubMed ID: 1519930
[TBL] [Abstract][Full Text] [Related]
2. [A synchronous double cancer of esophagus and stomach treated with 5-fluorouracil and consecutive low-dose cisplatin].
Kondo K; Akiyama S; Nonami T; Kasai Y; Hibi K; Ito K; Takagi H
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1839-42. PubMed ID: 7574819
[TBL] [Abstract][Full Text] [Related]
3. [Three cases of drug-induced hemolytic uremic syndrome].
Tohda S; Shiigai T; Jibiki M; Aoi T; Ueda Y; Kawasaki T; Kurokawa H; Nara N
Gan To Kagaku Ryoho; 1996 Feb; 23(3):361-4. PubMed ID: 8712831
[TBL] [Abstract][Full Text] [Related]
4. [Hemolytic-uremic syndrome caused by mitomycin C].
de Insausti CL; Gutiérrez LE
Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
[No Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience.
Strickland AH; Karapetis CS; Yip D; Harper PG
Clin Oncol (R Coll Radiol); 2001; 13(1):66. PubMed ID: 11292143
[No Abstract] [Full Text] [Related]
6. [A case of nonresectable esophageal cancer treated by the combination of cisplatin, 5-fluorouracil and THP-adriamycin].
Anai H; Toda T; Ichiyoshi Y; Miura O; Matsuzaki K; Minamisono Y; Nagasaki S
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1241-4. PubMed ID: 8333752
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated hemolytic uremic syndrome.
Hrozencik SP; Connaughton MJ
Oncol Nurs Forum; 1988; 15(6):755-9. PubMed ID: 3205834
[No Abstract] [Full Text] [Related]
8. [Complete response in a case of advanced esophageal and gastric double cancer treated by chemotherapy of TS-1 and low-dose cisplatin].
Yasumura T; Maruyama T; Kaji S; Yagawa A; Ozawa T
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2069-71. PubMed ID: 17197756
[TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
Tanaka N; Inoue F; Takeda I; Mori T; Miyake M; Mimura H; Orita K
Gan To Kagaku Ryoho; 1988 Jan; 15(1):59-66. PubMed ID: 2447836
[TBL] [Abstract][Full Text] [Related]
10. [Mitomycin C associated hemolytic uremic syndrome--a case report and review of the Japanese cases].
Shirakawa K; Morita S; Tojo M; Tsuda M; Uchida R; Mimoto H; Hatamori N; Okabayashi Y; Saeki S; Oimomi M
Gan To Kagaku Ryoho; 1993 Oct; 20(13):2057-61. PubMed ID: 8215482
[TBL] [Abstract][Full Text] [Related]
11. [A case of synchronous esophageal and gastric cancer successfully treated by combination TS-1/CDDP therapy with irradiation].
Takemura M; Osugi H; Lee S; Taguchi S; Kaneko M; Tanaka Y; Fukuhara K; Fujiwara Y; Nishizawa S; Kinoshita H; Harada S
Gan To Kagaku Ryoho; 2004 Feb; 31(2):251-4. PubMed ID: 14997762
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
Mergenthaler HG; Binsack T; Wilmanns W
Oncology; 1988; 45(1):11-4. PubMed ID: 3124028
[TBL] [Abstract][Full Text] [Related]
13. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
14. [Antiblastic chemotherapy in esophageal cancer].
Cartei G
Radiol Med; 1983; 69(7-8):597-600. PubMed ID: 6322245
[No Abstract] [Full Text] [Related]
15. Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma.
Bouillet T; Lepage E; Gisselbrecht C; Boiron M
Nouv Rev Fr Hematol (1978); 1990; 32(3):207-9. PubMed ID: 2120675
[TBL] [Abstract][Full Text] [Related]
16. O-MAX chemotherapy: high activity in metastatic esophagogastric adenocarcinoma and possible relation to subclinical hemolysis.
Ahlgren J; Patel N; Simmens S; Akin E; Bishop C; Kirkel D; Siegel P; Schuck S; Guebre-Xabiher H; Siegel R
Oncology; 2014; 87(6):371-80. PubMed ID: 25227924
[TBL] [Abstract][Full Text] [Related]
17. [A case of multiple advanced esophageal carcinomas with abdominal LN metastases showing complete response after chemoradiotherapy with concurrent cisplatin, 5-FU and adriamycin chemotherapy].
Yasuda T; Yano M; Takiguchi S; Kimura Y; Fujiwara Y; Monden M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1737-40. PubMed ID: 14619507
[TBL] [Abstract][Full Text] [Related]
18. [A five-year-survival case in which complete response was recognized after combined chemotherapy using 5-fluorouracil, adriamycin and mitomycin C (FAM) for unresectable gastric cancer].
Iwase K; Takenaka H; Sumimura J; Ishizaka T; Takagaki M; Bessho T; Ohata T; Inoue M; Oshima S; Tanaka T
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2235-7. PubMed ID: 1444491
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancer.
Li M; Zhang J; Wang D; Zhong B; Tucker S; Lu C; Cheng J; Cao C; Xu J; Xu J; Pan H
Anticancer Drugs; 2009 Nov; 20(10):941-5. PubMed ID: 19745719
[TBL] [Abstract][Full Text] [Related]
20. [A case of gastric cancer with Borrmann type 4 responding to 5-FU-MMC combined chemotherapy].
Hirama K; Mikami Y; Nishi T; Suzuki H; Sugiyama Y; Konn M
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2497-9. PubMed ID: 7944497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
